Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALENCE: Sofosbuvir + Ribavirin in GT2/3 HCV
NCT01682720Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Sep 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of sofosbuvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Sep 2012; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01682720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01682720.